INTRODUCTION
Addition of estrogens (Claus et al., 1989) , PGF 2α (Henze and Jurk, 1986, Pena et al., 2000) , and oxytocin (Baker at al., 1968 , Pena et al., 1998 to boar semen has been used to improve reproduction with AI. Estrogens are present in high concentrations in boar semen (Claus et al., 1990) and have been shown to stimulate myometrial contractions (Langendijk et al., 2002a) by causing release of PGF 2α from the endometrium (Claus et al., 1987) . The addition of PGF 2α to semen is reported to increase litter size, farrowing rate (Henze and Jurk, 1986; Pena et al., 2000) , and myometrial contractions (Langendijk et al., 2002a) but the results have not always been consistent (Flowers and Esbenshade, 1993) . Supplementation of oxytocin to semen has also increased farrowing rates in some cases but this effect was also inconsistent (Flowers and Esbenshade, 1993) . However, Pena et al. (1998) reported that litter size and farrowing rates were improved by oxytocin during the periods of seasonal infertility in the summer months. Collectively, the impact of the addition of these hormones to semen yielded inconsistent results, which has raised the question of the need, efficacy, and mechanism of action for these hormones for improving fertility with AI. Therefore, to address the potential benefit of hormone addition to extended semen for improving the efficiency of AI, this study was based on a sensitive fertility model using only a single low dose insemination (0.5 x 10 9 sperm/ 80 mL) to mimic a situation of compromised fertility. The study determined the effect of one of three hormones supplemented in boar semen (estrogens, PGF 2α , or oxytocin) on: 1) semen backflow following AI, 2) the number of sperm in the uterus and anterior segment of the uterus 8 h after AI, 3) frequency, amplitude and duration of uterine contractions following AI, and 4) pregnancy rate and litter size at 25 to 30 d post-mating.
MATERIALS AND METHODS

Experiment 1
This experiment evaluated the effect of hormone supplementation to extended semen on backflow (the volume of semen and number of sperm expelled from the vulva following AI), pregnancy at d 25 to 30 and number fetuses at d 25 to 30, placental weight, and fetal weight. Prepubertal gilts (n = 120), 170 ± 10 d of age weighing an average of 113 ± 10 kg of mixed genetics (Landrace-York, Landrace-York-Duroc, and Duroc) were given an injection of PG600  (400 IU PMSG and 200 IU hCG, Intervet Inc., Millsboro, DE) to induce estrus.
Twelve hours after injection, a mature boar was brought to the gilts for fence-line estrous detection, which consisted of nose-to-nose contact for 10 min and back pressure applied from a technician. Estrus detection occurred every 12 h until the onset of estrus which was determined as the first standing response to a boar using the back-pressure test. An animal had to display two consecutive standing responses to be considered in estrus. After standing estrus was confirmed the gilts were randomly allotted to treatment based on age, genetics, and BW and then moved into gestation stalls.
A proportion of the gilts were used to quantitate backflow after expressing estrus and assignment to treatment (n = 48). Gilts were assigned to receive a single insemination of 0.5 x 10 9 sperm in 80 mL of extender (Androhep Plus  , Minitube of America, Verona, WI) 24 h after the onset of estrus. Gilts received an AI with semen containing no hormone (C, control, n = 12), 11.5 µg estrogens (E, 5 µg of estradiol-17β, 4.5 µg estrone sulphate, and 2 µg estrone, n = 11), oxytocin (OT, 4 IU, n = 12), or PGF 2α (PG, 5 mg Lutylase  ; Pharmacia Co.., Peapack,, NJ, n = 13). The semen used for the study was a pool from three commercially owned boars of known fertility. One hour before insemination, all gilts were checked to ensure that all animals were still in standing estrus when insemination was performed at 24 h after onset of estrus. Immediately prior of insemination, the hormones were added to the semen. All animals were inseminated with a spirette catheter (Minitube of America, Verona, WI) using semen less than or equal to 72 h old.
Backflow of semen for each treatment was collected continuously using a modified foam tip catheter (Minitube of America, Verona, WI), which was locked in the cervix. The catheter was modified to extend ~5.0 cm distal of the vulva and was attached to a 50-mL conical shaped centrifuge tube. Backflow samples were collected at 0, 0.25, 0.5, 1, 2, 4, and 8 h relative to insemination. During insemination, (time 0) a 200-mL cup was held beneath the vulva to collect effluent. Backflow samples were collected and stored at 5 °C, and evaluated for volume and sperm number. Following AI, gilts were moved to 1.8 x 3.5 m pens and housed in groups of four to six until slaughter (n = 120). Reproductive tracts were collected at slaughter and assessed for ovulation rate (number of corpora lutea, CL), pregnancy, number of fetuses, fetal weight, and placental weight at 25 to 30 d after AI. The total number of fetuses were counted in addition to the number of degenerative and healthy fetuses. Degenerative fetuses were distinguished from healthy fetuses based on appearance, and smaller weight (>1 g lower than the average of all fetuses), and appeared to be in the process of being absorbed.
Experiment 2
This experiment evaluated the effect of hormone addition to semen on the number of sperm retained in specific sections of the reproductive tract following AI. Prepubertal gilts (n = 7 / treatment) were induced into estrus, checked for estrus, and inseminated similar to procedures used for Exp. 1. Backflow was also collected for 8 h to account for number of sperm lost before the tracts were obtained. After the last backflow sample was collected, animals were anesthetized with an i.m. injection of 2.5 mg / kg BW each of tiletamine and zolazepam, ketamine, and xylazine (Fort Dodge Animal Health, Fort Dodge, IA). This was followed immediately by stunning using a captive bolt, and euthanasia by jugular exanguination. The reproductive tracts were removed within 10 to 15 min after sedative injection. The oviduct was flushed in addition to a 10 cm segment of the anterior uterus, just adjacent to the uterotubal junction. The uterine horns were first ligated with umbilical tape placed 10 cm from the utero-tubal junction on the uterine side and a second ligature placed on the infundibulum side of the ampullary region of the oviduct. Hemostats were placed near both of the tape locations and a blunt end 18-gauge needle was inserted near the uterotubal junction to perform a retrograde flush of the oviduct. The oviduct was infused with 10 mL of 0.9% (wt/vol) NaCl, and gently massaged to free any sperm lodged in crypts. To collect effluent, the opposite end of the oviduct was placed in a 15 mL centrifuge tube and then the hemostats were removed and the volume massaged from the oviduct. The same procedure was followed for flushing the uterus except that a 14-gauge needle was used to infuse fluids, and a 50 mL centrifuge tube was utilized as the collection container. Subsequent to flushing, all collections were centrifuged at 1200 x g for 3 min and supernatant was removed, leaving 1 mL in the tubes with the cellular pellet. The centrifuged tubes were placed in a -20 °C freezer overnight to lyse any red blood cells. The next day, the pellet was re-suspended and the concentration of sperm evaluated using a hemacytometer.
Experiment 3
This experiment evaluated the effect of hormone supplementation to extended semen on the frequency, duration, and amplitude of uterine contractions. Sows (n = 3 / treatment) were checked for estrus in crates every 12 h starting 24 h after weaning using a mature boar. Once estrus was detected, sows were assigned to treatment based on lactation length, parity, and genetics. Uterine contractions were measured using a MIKRO-TIP  catheter pressure transducer (Millar Instruments Inc., Houston, TX). The transducer was pressure calibrated using a mercury manometer according to the recommendations of the manufacturer. Twenty-four hours after the onset of estrus, a modified intrauterine catheter (I.M.V. International, Maple Grove, MN) was placed into the uterine body just anterior to the cervix. The tip of the inner catheter was bored out with a 0.8 cm drill bit to enable the transducer to be inserted through the catheter into uterus. Twenty-four hours after the onset of estrus, a modified intrauterine catheter (I.M.V. International, Maple Grove, MN) was placed into the uterine body just anterior to the cervix.
Once in position, the transducer was attached to a physiograph to record uterine contractions for 1 h prior to AI and for 2 h after AI. The physiograph was calibrated with the pressure transducer to record contractions between 10 to 60 mmHg. The criteria for defining a contraction event was based on the amplitude deviation from baseline and the duration of time that pressure was above baseline.
Semen processing
Sperm rich fractions from boar ejaculates were collected from a commercial boar stud and semen from the same three boars was used for all experiments. After collection, the fractions were pooled and extended at a ratio of one to one with extender to preserve the semen until further analysis. In the lab, sperm concentration was adjusted to 0.5 x 10 9 fertile sperm / 80 mL based on motility, morphology, and viability tests.
RESULTS
Experiment 1
For backflow, there was a treatment by time interaction (P < 0.001). During insemination (0 h), gilts receiving PG treatment lost 4 times more (26.0 mL) semen compared to controls (8.5 mL) and more than twice (13.7 mL) the volume of gilts receiving estrogen or oxytocin (P < 0.0001, Table 1 ). There was no difference among treatments in backflow from 0.25 to 1 h after insemination (P > 0.70) even though the control gilts lost 11.5 mL more than the other treatments. Between one and two hours following AI, the volume of semen backflow was also not different among treatments, even though the estrogen (16.6 mL) treatment lost an average of 10 mL more at this time than either the oxytocin and PG treatments (5.6 and 1.9 mL, respectively), and 5 mL more than controls. By the end of the 8 h following AI, there was no difference in the total volume of backflow even though the OT treatment expelled 12 mL less than the other treatments.
Similar to volume, there was a treatment by time interaction (P < 0.05) for the total number of sperm lost in the backflow. During insemination, 20% of the total sperm inseminated (97.0 x 10 6 sperm) was lost for the PG treatment compared to 8% (40.0 x 10 6 sperm) for the controls (P < 0.01, Table 2 ). The estrogen and oxytocin treatments lost an average of 14% of the sperm (77.5 x 10 6 sperm), but were not different from the PG or the control groups. By 8 h, the control group expelled 54% of the total sperm inseminated (270 x 10 6 sperm) compared to 34% (170 x 10 6 sperm) for PG, 38% (190 x 10 6 sperm) for estrogen, and 42% (210 x 10 6 sperm) for the oxytocin treatments.
At d 25 to 30 following AI, pregnancy rates (59.0 ± 0.1%) were not different (P > 0.60, Table 3 ) among hormone treatment groups. However total number of fetuses (calculated from the total number of gilts pregnant and including both healthy and degenerative fetuses) was influenced by treatment (P < 0.04). The total number of fetuses (adjusted for number of CL) was greater (P < 0.02) for PG (10.2), and tended (P < 0.06) to be greater for oxytocin (10.0), but not for estrogen (9.3) compared to controls (7.5). The number of healthy fetuses was also influenced by treatment (P < 0.04). The number of healthy fetuses was increased (P < 0.04) by PG (8.7) and tended (P = 0.06) to be greater for oxytocin (8.4), but not for estrogen (7.2) compared to controls (5.8). Embryo survival (%) was influenced by ovulation rate (P < 0.05) and was not influenced by treatment even though means were numerically higher in the hormone treatments compared to controls (Table 3) . Embryo survival was observed to decrease 1.4% for each increase in number of CL. Overall, there was no difference in ovulation rate (15 ± 2.7 CL) or number of degenerative fetuses (1.7 ± 0.5) among treatments (P > 0.10). However, there was a difference in placental weight among the treatments (P < 0.01). Placenta for the PG group averaged 22.3 ± 1.0 g compared to 24.6 ± 1.5 g for the other treatments. There was no difference in fetal weights among treatments (P > 0.50) and each fetus averaged 1.6 ± 0.1 g.
Experiment 2
There was no difference (P > 0.20) in the number of sperm that were flushed out between the left and right oviducts or the left and right 10 cm segments of the anterior uterine horns, and therefore data from both oviducts and both uterine horns were pooled (Table 4 ). The volume of semen leakage at time 0, during insemination tended (P < 0.07) to be lowly correlated to sperm numbers retained in the anterior segments of the uterus (r = -0.30) but not the oviducts (P > 0.50). There was a trend (P = 0.10) for the hormone treatments to have more sperm (6.0 x 10 4 sperm) in the anterior uterine segments compared to the controls (2.2 x 10 4 sperm). However, there was no difference among treatments (P > 0.80) for the total number of sperm flushed from the oviducts (3.2 ± 1.3 x 10 4 sperm, Table 4 ).
Experiment 3
Prior to insemination, sows averaged 5.6 ± 0.6 uterine contractions / h with an average amplitude of 50.4 ± 2.1 mmHg, and with an average duration of 41.2 ± 6.2 s. The frequency of contractions for the controls appeared to increase from 5.2 / h prior to AI to 11 / h in the 2 h following AI, but this was not significant (P > 0.10). Following AI, there was a treatment x time effect (P < 0.001) for frequency of uterine contractions. At 0.5 h after insemination, the PG group had more than twice the number of contractions (P < 0.005) compared to the other treatments (14.2 vs 6.5 / h). At 1 h and continuing until the second hour following AI, there was no difference in the number of contractions among treatments (P > 0.40). There was no effect of treatment (P > 0.10) on the duration (35.1 ± 5.4 ) or amplitude (54.2 ± 2.1 mmHg) of uterine contractions. However, there was an effect of time (P < 0.003) for the duration of uterine contractions. Similar patterns were observed for the changes in the duration of uterine contractions over time for all of the treatments. The duration of contractions was greater before insemination (39.8 s) and then decreased at 0.5 h after insemination (28.6 s) before increasing at 1 h following AI (37.4 s).
DISCUSSION
Hormone addition to semen or injection into females prior to or during insemination has been reported in some cases to increase fertility in swine in summer months and in lower parity sows. In the present study, to evaluate the effect of hormone addition to semen, we used a model to simulate a situation of lowered fertility. The low number of fetuses (< 6) and pregnancy rates (62%) in the control treatment indicated that a situation of compromised fertility was achieved using a single insemination of 0.5 x 10 9 sperm in prepubertal gilts induced into estrus. These results indicate that hormone addition to the semen did not improve pregnancy rates but did increase the total number of fetuses when compared to no hormone addition. However, the mechanism for this effect is unclear. With the exception of contraction frequency immediately following insemination with PG, it was not possible to detect any clear effect of hormone addition on characteristics for frequency, duration or amplitude of uterine contractions during a 2-h period following administration of hormone in the semen. Although total sperm retained in the anterior uterine segment and oviduct together were not influenced by hormone addition, there was a trend for the total number of sperm retained in the anterior segments of the uterus alone to be increased by 10% or more for all of the hormone treatments compared to the controls. However, the increased sperm numbers in the uterus did not translate into increased numbers of sperm in the oviduct 8 h after insemination. These data indicate that in situations of lowered fertility, the addition of prostaglandin or oxytocin could aid in establishing uterine sperm reservoirs, which can minimize the risk of lowered litter size.
The impact of hormone addition to semen has been observed when low fertility situations exist, such as during summer or in lower parity sows. In this study, a single low dose AI simulated a situation of reduced fertility. Hormone addition to semen altered the pattern of fluid and sperm loss following AI. This was associated with a trend for an increase in sperm retained within the anterior segment of the uterus and with an increased total number of pigs. Prostaglandin (1 cc of a 5 mg/ mL Lutalyse) and oxytocin (4 IU, 0.2 mL of 20 IU solution), may be the best choices for minimizing situations of compromised fertility. From these findings hormone addition to semen may be useful during situations where the risk of compromised fertility is high. However, before hormones are added to semen, efforts should be directed toward accurate detection of estrus, optimizing semen quality, and proper AI timing and technique. Myometrial activity around estrus in sows: spontaneous activity and effects of estrogens, cloprostenol, seminal plasma and clenbuterol. Theriogenology. 57:1563-1577. Pena, F. J., J. C. Dominguez, L. Carbajo, L. Anel, and B. Alegra. 1998. Treatment of swine summer infertility syndrome by means of oxytocin under field conditions. Theriogenology 9:829-836. A single insemination utilizing 0.5 x 10 9 sperm / 80 mL was performed 24 h (0 h) after the onset of estrus. b The number of gilts receiving no hormone (CONTROL, n = 12), 11.5 µg estrogens (E) / 80 mL (n = 11), 4 IU oxytocin (OT) / 80 mL (n = 12), or 5 mg PGF 2α (PG) / 80 mL (n = 13) in semen immediately prior to AI (treatment x time, P < 0.001). Fetal wt, g 1.6 1.7 1.5 1.5 0.1 b Gilts in the each treatment received no hormone (CONTROL, n = 29), 11.5 µg estrogens (E, n = 31) / 80 mL, 4 IU oxytocin (OT, n = 30) / 80 mL, or 5 mg PGF 2α (PG, n = 30) / 80 mL immediately prior to AI. The number of gilts receiving no hormone / 80 mL (CONTROL, n = 7), 11.5 µg estrogens (E) / 80 mL (n = 7), 4 IU oxytocin (OT) / 80 mL (n = 7), or 5 mg PGF 2α (PG) / 80 mL (n = 7) in semen immediately prior to AI. The oviducts were flushed as well as a 10 cm anterior section of the uterus adjacent to the uterotubal junction. d SE = Pooled standard error. e A trend was observed (P = 0.10) for numbers of sperm in the uterus among hormone treatments and CONTROL. f No difference (P > 0.10) for sperm in the oviducts.
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